wellrank.ai

Is compounded tirzepatide still available anywhere legitimate?

ClaudequalifiedCollected Jul 1, 2026, 13:57 UTC

Verbatim response from Claude

Compounded Tirzepatide Availability

This is a rapidly changing situation, so here's the current landscape:

What Happened

The FDA removed tirzepatide (Zepbound/Mounjaro) from its shortage list in late 2024, which triggered a ban on most compounded versions. Many compounding pharmacies had to stop producing it.

Still Potentially Legitimate Options

503A Compounding Pharmacies (patient-specific prescriptions):

  • May still compound for patients with documented allergies or specific clinical needs
  • Requires a legitimate prescription and documented medical justification

Some Telehealth Platforms Still Navigating This:

  • Hims & Hers - has been working through compliance issues
  • LifeMD - adjusting offerings
  • Henry - similar situation

Important Caveats

  • The FDA has been actively enforcing against unapproved compounded versions
  • Any current availability may change within weeks or months
  • Verify any pharmacy is PCAB-accredited or an FDA-registered 503B facility

Honest Recommendation

Check with:

  1. Your doctor directly
  2. Cost Plus Drugs (costplusdrugs.com) for transparency
  3. Manufacturer savings programs for brand-name Zepbound

The situation is genuinely fluid - I'd verify current status directly with providers before committing.

Brands mentioned in this answer

Is this answer wrong about your brand?

AI engines repeat outdated pricing, wrong ingredients, and misread positioning every day. Tell us what this answer gets wrong and we will include a correction review in your free AI Visibility Audit.

This answer is reproduced verbatim from the engine's API at collection time and may contain errors or outdated claims. It is presented as evidence of what AI engines tell buyers, not as medical or purchasing advice.

Is your brand missing from this answer?

Get your AI Visibility Audit: every buyer intent question you are losing, who wins them, and the sources that decide the answer.